Millennium Management Portfolio holdings
Millennium Management, founded in 1989 by Israel (Izzy) Englander and Ronald Shear and headquartered in New York City, is a global multi-strategy hedge fund managing over $71 billion in assets as of late 2024, employing a decentralized model with over 300 independent trading teams. Operating across equities, fixed income, commodities, currencies, and derivatives, the firm uses a mix of quantitative and fundamental strategies, providing its portfolio managers with capital, infrastructure, and autonomy to pursue diverse investment approaches while enforcing strict risk management. With more than 5,400 employees across offices in London, Hong Kong, Singapore, and beyond, Millennium has evolved from its initial $35 million seed capital—partly from the Belzberg family—into a titan of the hedge fund world, known for its ability to attract top talent and deliver consistent returns. Under Englander’s leadership as chairman and CEO, the firm remains a low-profile yet highly influential force in global finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Merck
MRK
|
+$216M |
| 2 |
Apple
AAPL
|
+$215M |
| 3 |
KeyCorp
KEY
|
+$212M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$210M |
| 5 |
Synchrony
SYF
|
+$204M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
DuPont de Nemours
DD
|
+$1.82B |
| 2 |
Comcast
CMCSA
|
+$427M |
| 3 |
Amazon
AMZN
|
+$418M |
| 4 |
SLB Ltd
SLB
|
+$312M |
| 5 |
Ameren
AEE
|
+$257M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 12.03% |
| 2 | Energy | 10.22% |
| 3 | Consumer Discretionary | 9.15% |
| 4 | Financials | 9.09% |
| 5 | Industrials | 8.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
626
Burlington
BURL
$23.2B
| $17.7M | 0.04% |
411,849
+167,692
| +69% | +$7.77M |
|
|
PKY
627
DELISTED
Parkway, Inc.
PKY
| $17.7M | 0.04% |
1,129,565
-260,026
| -19% | -$4.27M |
|
628
Herc Holdings
HRI
$5.02B
| $17.6M | 0.04% |
411,268
+387,988
| +1,667% | +$19.5M |
|
|
629
CALL
DuPont de Nemours
DD
$18.5B
| $17.5M | 0.04% |
134,260
+35,540
| +36% | +$4.56M |
|
630
Archrock
AROC
$6.27B
| $17.5M | 0.04% |
2,323,880
-417,713
| -15% | -$5.97M |
|
631
Workday
WDAY
$39.6B
| $17.4M | 0.04% |
218,514
+125,551
| +135% | +$10M |
|
|
CNCE
632
DELISTED
Concert Pharmaceuticals, Inc.
CNCE
| $17.4M | 0.04% |
915,625
-55,394
| -6% | -$1.2M |
|
|
WOOF
633
DELISTED
VCA Inc.
WOOF
| $17.3M | 0.04% |
314,885
-316,957
| -50% | -$17.4M |
|
634
DigitalBridge
DBRG
$2.93B
| $17.3M | 0.04% |
355,828
-55,959
| -14% | -$3.01M |
|
635
Lear
LEA
$6.54B
| $17.3M | 0.04% |
140,538
+52,491
| +60% | +$6.39M |
|
|
AET
636
DELISTED
Aetna Inc
AET
| $17.2M | 0.04% |
158,792
-537,812
| -77% | -$58.1M |
|
637
Karyopharm Therapeutics
KPTI
$43.5M
| $17.1M | 0.04% |
86,290
+17,908
| +26% | +$3.88M |
|
638
Republic Services
RSG
$64.8B
| $17.1M | 0.04% |
389,537
-134,157
| -26% | -$5.85M |
|
639
Novartis
NVS
$297B
| $17.1M | 0.04% |
221,219
+73,365
| +50% | +$5.83M |
|
|
ANAC
640
DELISTED
ANACOR PHARMACEUTICALS INC COM
ANAC
| $17M | 0.04% |
150,537
-1,035,070
| -87% | -$114M |
|
641
Sunstone Hotel Investors
SHO
$2.19B
| $17M | 0.04% |
1,357,458
+1,334,859
| +5,907% | +$18.9M |
|
|
OTIC
642
DELISTED
Otonomy, Inc.
OTIC
| $16.9M | 0.04% |
609,929
+585,693
| +2,417% | +$14.6M |
|
|
QTS
643
DELISTED
QTS REALTY TRUST, INC.
QTS
| $16.9M | 0.04% |
373,914
-40,576
| -10% | -$1.77M |
|
|
IMPV
644
DELISTED
Imperva, Inc.
IMPV
| $16.8M | 0.04% |
264,863
+175,472
| +196% | +$11.9M |
|
645
Bank of Montreal
BMO
$126B
| $16.8M | 0.04% |
297,071
-259,149
| -47% | -$14.9M |
|
646
Whirlpool
WHR
$2.43B
| $16.7M | 0.04% |
113,971
-337,441
| -75% | -$52.4M |
|
|
STRZA
647
DELISTED
Starz - Series A
STRZA
| $16.7M | 0.04% |
+499,221
| New | +$17.8M |
|
648
Orthofix Medical
OFIX
$477M
| $16.6M | 0.04% |
424,249
+94,442
| +29% | +$3.53M |
|
649
Old Republic International
ORI
$10.5B
| $16.4M | 0.03% |
878,141
+147,330
| +20% | +$2.65M |
|
650
Acadia Pharmaceuticals
ACAD
$4.43B
| $16.4M | 0.03% |
458,785
-336,240
| -42% | -$11.8M |
|
Similar funds
Millennium Management's Q4 2015 Portfolio in Review
As of Q4 2015, Millennium Management held 4,144 positions worth $47.6B, down 7.9% from $51.6B the previous quarter. Its ten largest holdings account for 10% of the portfolio.
Millennium Management withdrew a net $5.89B in Q4 2015, closing 779 positions and reducing 1,349 holdings. Its most notable exit was Illumina, an estimated $86.9M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 12% of assets, up from 11% a quarter earlier, followed by Energy and Consumer Discretionary.
Against the trend, Millennium Management opened a new position in Alphabet (Google) Class A worth $221M.
- Millennium Management's largest Q4 2015 buy was Alphabet (Google) Class A: 5,673,120 shares worth $221M.
- Millennium Management added most to Merck in Q4 2015, an estimated $216M increase.
- Millennium Management's biggest Q4 2015 reduction was DuPont de Nemours, cutting an estimated $1.82B.
- Millennium Management fully exited Illumina in Q4 2015, selling an estimated $86.9M.
- Millennium Management's ten largest holdings make up 10% of its $47.6B portfolio in Q4 2015.
- Millennium Management opened 733 new positions and closed 779 in Q4 2015.
- Millennium Management's portfolio value fell 7.9% quarter-over-quarter to $47.6B.
Based on Millennium Management's 13F filing for Q4 2015, filed 16 Feb 2016.